-
March of Dimes and Ferring announce new Prematurity Research Center at Imperial College London
inMarch of Dimes and Ferring Pharmaceuticals today announced that March of Dimes has selected Imperial College London…
-
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage
inFerring Pharmaceuticals and MSD, known as Merck & Co., Inc., Kenilworth, N.J., U.S.A., through its MSD for Mothers initiative…
-
Ferring announces 30 million CHF investment in new biotech centre in Switzerland
inFerring Pharmaceuticals announced today that it is expanding its capabilities in biologics through a new biotech centre…
-
Ferring Announces Recipients of Innovation Grants Program 2017-2018
inFerring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute…
-
Ferring enters into worldwide OmniAb® platform license agreement with Ligand
inFerring Pharmaceuticals announced today that it has entered into a worldwide license agreement with Ligand Pharmaceuticals to use…
-
Ferring and the Chinese Academy of Sciences collaborate to advance research in reproductive medicine
inFerring Pharmaceuticals and the Chinese Academy of Sciences (CAS) today announced a long-term collaboration to advance basic…
PRESS RELEASE 2018
PRESS RELEASE 2018